[Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
Uemura
T
T
Department of Obstetrics and Gynecology, Yokohama City.
Yoshimura
Y
Y
Ishikawa
M
M
Asukai
K
K
Minaguchi
H
H
D000735:Androstenedione / Q000097:blood; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008596:Menotropins / Q000009:adverse effects / Q000627:therapeutic use*; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D000735:Androstenedione; D004958:Estradiol; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone